| Minimally invasive: Safe endoscopic
procedure with sedation, takes 15-20
minutes. | Temporary effect: Lasts 6-12 months,
60% of patients require repeat treatment. |
| High safety: 98.5% success rate and
99.2% safety rate in the 27-35 BMI
range. | Limited suitability: Success rate
drops to 45% for BMI >35. |
| Effective weight loss: 4-5 kg in the
first month, 3-4 kg in the second
month, 2-3 kg in the third month. | Certain contraindications: Cannot be
used in myasthenia gravis,
pregnancy, or breastfeeding. |
| Rapid recovery: Liquid diet after 2-3
hours, normal diet within 48 hours. | Side effects: Swallowing difficulty
(15-20%) in the first week, abdominal
pain (25-30%), nausea (10-15%). |
| Cost-effective: 60-70% more
affordable than bariatric surgery. | Variable results: 6-month weight loss
of 8-15 kg depending on metabolism. |
| Versatile: Reduces gastric motility by
60-70%, improves reflux by 85%. | Risk groups: Contraindicated in
patients on anticoagulants and with
active ulcers. |
| Repeatable: Can be renewed with
95% success after 6-12 months. | Limited data: 82% success in 5-year
follow-ups, long-term results
uncertain. |
